Log in to save to my catalogue

Harmonization of molecular monitoring of CML therapy in Europe

Harmonization of molecular monitoring of CML therapy in Europe

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_734135595

Harmonization of molecular monitoring of CML therapy in Europe

About this item

Full title

Harmonization of molecular monitoring of CML therapy in Europe

Publisher

London: Nature Publishing Group UK

Journal title

Leukemia, 2009-11, Vol.23 (11), p.1957-1963

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The high efficacy of the standard treatment of chronic myeloid leukemia (CML) with imatinib has prompted the need for accurate methods to monitor response at levels below the landmark of complete cytogenetic remission. Quantification of
BCR–ABL
transcripts has proven to be the most sensitive method available, and has shown prognostic impact w...

Alternative Titles

Full title

Harmonization of molecular monitoring of CML therapy in Europe

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_734135595

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_734135595

Other Identifiers

ISSN

0887-6924

E-ISSN

1476-5551

DOI

10.1038/leu.2009.168

How to access this item